The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

As Medicare turns 60, Medscape convened an expert panel to discuss the use of AI in medicine, physician reimbursement, and ...

As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Even in people without high blood pressure, subclinical primary aldosteronism is linked to a significantly higher risk for ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

The Mediterranean diet has long been touted as one of the healthiest diets in the world, but childhood obesity in Greece has ...

This is especially true for older adults with type 2 diabetes (T2D) taking insulin and/or sulfonylureas — steadfast older ...

Biomarker panel based on capsule Cytosponge could simplify Barrett esophagus surveillance and reduce endoscopies in low-risk ...

Preliminary data from clinical trials of tecovirimat as a treatment for mpox virus infection have given disappointing results ...

Psychiatrists challenge common suicide myths and explain why smiling patients still face life-threatening risks.